Differentiating Carotid Free-Floating Thrombus From Atheromatous Plaque Using Intraluminal Filling Defect Length on CTA: A Validation Study.
Carlos TorresCheemun LumPaulo PuacGrant StottsMichel Christopher Frank ShamyDylan BlacquiereRonda LunPrasham DaveAditya BharathaBijoy K MenonRebecca E ThornhillFranco MomoliDariush DowlatshahiPublished in: Neurology (2021)
This study provides Class I evidence that in patients with TIA/stroke symptoms, the presence of CTA-identified filling defects of lengths >3.8 mm accurately discriminates FFT from atheromatous plaque.